Man

Juan Pablo Undurraga Fourcade

Psychiatrist

Facultad de Medicina Clínica Alemana Universidad del Desarrollo

Santiago, Chile

Líneas de Investigación


Main research interests: early psychosis, mood disorders and psychopharmacology.

Educación

  •  PhD Medical Sciences, UNIVERSIDAD DE BARCELONA. España, 2013
  •  Psychiatry Specialist, HOSPITAL CLINICO DE BARCELONA. España, 2011
  •  MD, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2004

Experiencia Académica

  •   Associate Professor Other

    UNIVERSIDAD DEL DESARROLLO

    Medicine

    Santiago, Chile

    2014 - A la fecha

  •   Clinical Assistant Professor, Psychiatrist, Researcher Full Time

    HOSPITAL CLINICO DE BARCELONA

    Medicine

    Barcelona, España

    2011 - 2014

  •   Research Fellow Other

    HARVARD UNIVERSITY

    Belmont, MA, Estados Unidos

    2011 - 2011

Experiencia Profesional

  •   Psychiatrist Other

    Clinica Alemana Universidad del Desarrollo

    Santiago, Chile

    2014 - A la fecha

  •   Clinical Researcher Full Time

    CIBERSAM. Mental Health Care Research Network of Spain

    Barcelona, España

    2011 - 2014

  •   Research Fellow, Psychopharmacology dpt Full Time

    McLean Hospital, Harvard Medical School

    Belmont, MA, Estados Unidos

    2011 - 2011

  •   Psychiatry Resident Full Time

    Hospital Clínic de Barcelona

    Barcelona, España

    2007 - 2011

  •   General Practitioner, Centro Salud Familiar Madre Teresa de Calcuta Full Time

    Pontificia Universidad Católica de Chile

    Santiago, Chile

    2004 - 2006

  •   Psychiatrist and researcher, clinical professor Full Time

    Unidad Tr. Bipolar, Hospital Clínic de Barcelona

    Barcelona, España

    2011 - 2014

  •   Psychiatrist Part Time

    J. Horwitz Psychiatric Institue

    Santiago, Chile

    2014 - A la fecha

Formación de Capital Humano


2012 – 2013: Clinical Assistant Professor. Faculty of Medicine, Barcelona University.
Hospital Clínic i Provincial of Barcelona, Barcelona, Spain.
Residents and pregraduate medical students training.

2013- : Lecturer in the international course “Universitary Expert in Bipolar Disorder”.
Hospital Clínic of Barcelona, Barcelona University, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and Mental Health Care Research Network of Spain (CIBERSAM).

2013- : Invited Lecturer in “Bipolar Disorder Update”. Online Internacional course. Hospital Clínic of Barcelona, Latin American Psychiatric Association (APAL), Argentinean Psychiatrists Association (APSA).


Premios y Distinciones

  •   Emergent Researcher Award

    Spanish Society of Biological Psychiatry

    España, 2013

    Program for Research Excellence

  •   Article of the month (April 2012)

    Acta Psychiatrica Scandinavica

    Reino Unido, 2012

    For the article: Baldessarini RJ, Undurraga J, Vázquez GH, Tondo L, Salvatore P, Ha K, et al. Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatr Scand. 2012 Apr; 125(4): 293-302.

  •   Josep Font Research Fund

    HOSPITAL CLINICO DE BARCELONA

    España, 2011

    End of Residency Award. Awarded for the research project: "Specificity of prodromic symptoms in bipolar disorder and clinical course prediction". (3 years contract).

  •   Best Scientific Work

    IV Chilean Congress of Family Medicine

    Chile, 2004

    For the oral presentation: “Quality of care in general practice: development and validation of an instrument to measure the quality of clinical care”. Muñoz D, Pantoja T, Undurraga J. Viña del Mar, Chile.

  •   Travelling Research Grant

    Spanish Foundation for Psychiatry and Mental Health (FPSM).

    España, 2010

    Award given by the Spanish Foundation for Psychiatry and Mental Health (FPSM), the Spanish Society of Psychiatry and the Spanish Society of Biological Psychiatry.


 

Article (72)

Emotional Intelligence: a comparison between patients with First Episode Mania and those suffering from a Bipolar Disorder type I.
Gender, age and geographical representation over the past 50 years of schizophrenia research
Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium
Functional Dysconnectivity in Ventral Striatocortical Systems in 22q11.2 Deletion Syndrome
Intervención Temprana en Psicosis, una Mirada Clínica.
Pharmacogenetics in Psychiatry: Perceived Value and Opinions in a Chilean Sample of Practitioners
Predictors of clozapine discontinuation at 2 years in treatment-resistant schizophrenia
Structural brain abnormalities in schizophrenia in adverse environments: examining the effect of poverty and violence in six Latin American cities
Antidepressant responses in direct comparisons of melancholic and non-melancholic depression
Cannabis use among hospitalized young people experiencing a first episode of psychosis: a case control study
The incidence of non-affective psychotic disorders in Chile between 2005 and 2018: results from a national register of over 30 000 cases.
A 12-month prospective study on the time to hospitalization and clinical management of a cohort of bipolar type I and schizoaffective bipolar patients
High prevalence of metabolic alterations in Latin American patients at initial stages of psychosis
Clinical characterization of rapid cycling bipolar disorder: Association with attention deficit hyperactivity disorder
Depressive symptoms are associated with higher morning plasma cortisol in primary care subjects
Depressive symptoms are associated with higher morning plasma cortisol in primary care subjects.
Early treatment resistance in a Latin-American cohort of patients with schizophrenia.
Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis
Duration of untreated psychosis and acute remission of negative symptoms in a South American first-episode psychosis cohort
Morbidity in Depressive Disorders
Safety, tolerability, and risks associated with first- and second-generation antipsychotics=> a state-of-the-art clinical review.
Psychoeducation in bipolar disorder with a SIMPLe smartphone application: Feasibility, acceptability and satisfaction
Implementing psychosocial evidence-based practices in mental health: Are we moving in the right direction?
Making sense of DSM-5 mania with depressive features
Predictors of functional outcome after a manic episode
Risk factors for rapid cycling in bipolar disorder
Self-monitoring and psychoeducation in bipolar patients with a smart-phone application (SIMPLe) project: design, development and studies protocols
The real world cost and health resource utilization associated to manic episodes: The MANACOR study
"Is bipolar disorder an endocrine condition?" Glucose abnormalities in bipolar disorder
"Is bipolar disorder an endocrine condition?" Glucose abnormalities in bipolar disorder.
Declining efficacy in controlled trials of antidepressants: effects of placebo dropout
e-HCL-32: a useful, valid and user friendly tool in the screening of bipolar II disorder
Early Medication Discontinuation on Long-term Recovery Outcome in First-Episode Psychosis
Early medication discontinuation on long-term recovery outcome in first-episode psychosis.
Pharmacological treatment of bipolar depression
Re-analysis of the earliest controlled trials of imipramine
Stratified medicine for mental disorders
Stratified medicine for mental disorders.
Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania
Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania.
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Overview of antidepressant treatment of bipolar depression
Overview of antidepressant treatment of bipolar depression.
Should obesity be a limiting factor for clozapine treatment?
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.
Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients
Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients.
Bipolar depression: Clinical correlates of receiving antidepressants
Bipolar depression: clinical correlates of receiving antidepressants.
Clozapine and agranulocitosis in Spain: Do we have a safer population? A 5-year hematologic follow-up
Clozapine and agranulocitosis in Spain: Do we have a safer population? A 5-year hematologic follow-up.
Olanzapine in Schizophrenia and Affective Disorders
Olanzapine in schizophrenia and affective disorders.
Origins of Psychiatric Hospitalization in Medieval Spain
Origins of psychiatric hospitalization in medieval Spain.
Predominant recurrence polarity among 928 adult international bipolar I disorder patients
Predominant recurrence polarity among 928 adult international bipolar I disorder patients.
Randomized, Placebo-Controlled Trials of Antidepressants for Acute Major Depression: Thirty-Year Meta-Analytic Review
Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review.
Risk factors for antidepressant-related switch to mania.
Suicidal Risk Factors in Bipolar I and II Disorder Patients
Suicidal risk factors in bipolar I and II disorder patients.
Brain germinoma presenting as a first psychotic episode in an adolescent male
Brain germinoma presenting as a first psychotic episode in an adolescent male.
Treatment of narcolepsy complicated by psychotic symptoms
Counseling: A comprehensive method to support the terminally ill.
Improving the quality of care in diabetes mellitus type 2: The implementation of a clinical practice guideline in primary care.
Quality of care in general practice: development and validation of an instrument to measure the quality of clinical care.
Post-herpetic neuralgia: Current evidence on prevention and treatment.
[Clozapine and agranulocitosis in Spain: do we have a safer population? A 5-year hematologic follow-up].

Abstract (3)

EARLY TREATMENT RESISTANCE IN A LATIN-AMERICAN COHORT OF PATIENTS WITH SCHIZOPHRENIA
Asenapine in the Treatment of Bipolar Disorder: New Insights From the Expasen Study
Understanding the real-world cost and burden of mania: the MANACOR study

BookSection (3)

Limitaciones de los tratamientos tradicionales del trastorno bipolar
Strategies for improving randomised trial evidence in treatment of bipolar disorder.
Valoración del trastorno bipolar de inicio precoz.

ConferencePoster (3)

Remission and functioning after two years undergoing Long-Acting Injectable Risperidone (LAIR) in recent-onset schizophrenia
Antipsychotic polipharmacy in schizophrenic inpatients
Cannabinoids receptors gene polymorphisms and anxiety traits

Letter (1)

Tricyclic and selective serotonin-reuptake-inhibitor antidepressants compared with placebo in randomized trials for acute major depression

Proyecto (11)

Early Identification of Treatment Resistance in Patients with First-Episode Psychosis
A CONNECTOMIC NEUROIMAGING STUDY OF THE 22Q11 DELETION SYNDROME=> A WINDOW INTO SCHIZOPHRENIA AND ITS GENETIC CAUSES
Impacto global del ejercicio fisico en usuarios con un primer episodio de esquizofrenia=> estudio randomizado-controlado
Network dynamics and neural circuits of the brain during resting state
Especificidad de los síntomas prodrómicos en el trastorno bipolar y predicción del curso clínico de la enfermedad.
Estudio longitudinal descriptivo para evaluar la salud física en primeros episodios afectivos.
Physical health in first affective episodes: a longitudinal, descriptive study.
Specificity of prodromic symptoms in Bipolar Disorder and clinical course prediction.
A prospective, randomized, double-blind, placebo-controlled, phase 2 safety and efficacy study of oral ELND005 as an adjunctive maintenance treatment in patients with bipolar I disorder.
International randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate(MEMAP).
International randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate(MEMAP).

Review (5)

Melancholia: does this ancient concept have contemporary utility?
Imaging Social and Environmental Factors as Modulators of Brain Dysfunction: Time to Focus on Developing Non-Western Societies
Lithium treatment for unipolar major depressive disorder: Systematic review
Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
Counseling: A comprehensive method to support the terminally ill
66
Juan Undurraga

Psychiatrist

Neurología y Psiquiatría

Facultad de Medicina Clínica Alemana Universidad del Desarrollo

Santiago, Chile

4
ALFONSO GONZALEZ

PROFESOR ASISTENTE

SALUD MENTAL

Universidad Finis Terrae

santiago, Chile

2
Tomás Ossandón

Associate Professor

Medical School, Department of Psychiatry

Pontificia Universidad Católica de Chile

Santiago, Chile

2
Nicolas Crossley

Assistant Professor

Psiquiatría

Pontificia Universidad Católica de Chile

Santiago, Chile

2
Maria Repetto

Profesor Titular

Center for Genetics and Genomics

FACULTAD DE MEDICINA CLINICA ALEMANA-UNIVERSIDAD DEL DESARROLLO

Santiago, Chile